Mold-Tek Pack.
Mold-Tek Pack. Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
2 of 4 strong
The short version
Volume growth target of 10% to 12% for the full year, despite challenges like the war and raw material issues. EBITDA per kg is expected to grow around 18% to 20%, driven by product mix changes, operational efficiencies, and consolidation.
From Mold-Tek Pack.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Volume growth target of 10% to 12% for the full year, despite challenges like the war and raw material issues.
- Paint segment expected to grow in the 10% to 15% range, with signs of acceleration, driven by increased IML adoption and capacity utilization.
- Food & FMCG and pharma segments growing rapidly, with Food & FMCG projected CAGR of 18%-20% and pharma at 40%-50% CAGR over 3-4 years.
- Pharma currently about 3.5% of overall sales but expected to grow significantly, aiming for INR 50-55 crores revenue, a ~50% YoY increase.
- EBITDA growth expected at 18%-20%, outpacing volume growth due to profitable product mix and operational efficiencies.
2 more points from Mold-Tek Pack.'s call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Mold-Tek Pack. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Q1 FY27 capex was around INR 20-22 crores.
- Total capex for FY27 is expected to be about INR 90 crores.
- INR 25-30 crores allocated for pharma.
- The balance for balancing and replacement.
- For medical devices (dosing pens and others), initial investment expected around INR 25-30 crores, including land and machinery.
- New construction ongoing: 25,000 sq ft facility for ophthalmic products to be completed in 6 months.
- No new consolidation of units planned beyond Hyderabad facility; focus on automation and efficiency improvements.
2 more points from Mold-Tek Pack.'s call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Industrial Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Mold-Tek Pack. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Currently, Mold-Tek Packaging Limited has orders from around 20-25 pharma companies.
- Additionally, approximately 10 more pharma companies are scheduled to visit and potentially place orders in the coming weeks or months.
- The company is actively expanding in pharma, medical devices, Food & FMCG sectors aside from traditional paint clientele.
- No specific quantitative value for the order book or pending orders is provided in the transcript, but increasing client interest and new visits indicate a growing order pipeline.
Mold-Tek Pack. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹238 Cr, net profit ₹21 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Mold-Tek Packaging Ltd's management said in earlier quarters
Arthneeti Pro · Annual
Mold-Tek Pack. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Mold-Tek Pack. Q1 FY27 results?
Volume growth target of 10% to 12% for the full year, despite challenges like the war and raw material issues. EBITDA per kg is expected to grow around 18% to 20%, driven by product mix changes, operational efficiencies, and consolidation.
What is Mold-Tek Pack. share price analysis?
Mold-Tek Pack. currently shows a below-average growth signal. The stock trades at a P/E of 31.0 with a market cap of ₹2,356 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mold-Tek Pack. planning capital expenditure?
Q1 FY27 capex was around INR 20-22 crores.
Keep Mold-Tek Pack. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.